ArticleScientific reports2026
Symptoms, risk factors, and health outcomes of long COVID in the United Arab Emirates.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Long COVID is an ongoing public health challenge. This study aimed to examine Long COVID in previously hospitalized COVID patients in the UAE, determine associated risk factors, and evaluate its influence on self-perceived health. A retrospective cohort study was conducted using medical records and in-depth telephone interviews with adult patients hospitalized for COVID-19 between January 2020 and October 2021. Hospitalization was primarily for COVID-19 illness, although early admissions also included quarantine or surveillance during the initial phase of the pandemic. All patients provided informed consent. The study assessed clinical predictors of Long COVID and its impact on patients’ daily lives. Long COVID was identified in approximately 49% of the 533 participants, with 43 distinct manifestations. Female sex, the number of initial symptoms, the need for intensive care during hospitalization, and having two or more comorbidities were associated with an increased risk of long COVID. It was also strongly linked to worsened self-rated health and overall poorer perceived health, as well as significant limitations in work functioning due to both physical and emotional difficulties. These findings highlight the need for structured post-acute follow-up and targeted support for higher-risk groups to mitigate the long-term clinical and public health burden of COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.